BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34043214)

  • 1. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
    Zhao L; Zhang Y; Liu F; Yang H; Zhong Y; Wang Y; Li S; Su Q; Tang L; Bai L; Ren H; Zou Y; Wang S; Zheng S; Xu H; Li L; Zhang J; Chai Z; Cooper ME; Tong N
    J Endocrinol Invest; 2021 Dec; 44(12):2709-2723. PubMed ID: 34043214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.
    Vaisar T; Durbin-Johnson B; Whitlock K; Babenko I; Mehrotra R; Rocke DM; Afkarian M
    Diabetes Care; 2018 Nov; 41(11):2361-2369. PubMed ID: 30150236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
    Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
    BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of decreased serum complement 3 in patients with diabetic nephropathy.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F
    Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients.
    Zhao L; Zou Y; Zhang J; Zhang R; Ren H; Li L; Guo R; Zhang J; Liu F
    Int J Med Sci; 2020; 17(14):2113-2124. PubMed ID: 32922172
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.
    Zhao L; Ren H; Zhang R; Wang T; Zou Y; Xu H; Li L; Cooper ME; Liu F
    Int Urol Nephrol; 2021 Jun; 53(6):1161-1170. PubMed ID: 33389518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
    An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z
    Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetic nephropathy progression in patients with type 2 diabetes mellitus: A biopsy-based study.
    Wu Y; Liu F
    J Diabetes Complications; 2022 Aug; 36(8):108235. PubMed ID: 35853763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.
    Yamakawa T; Kawaguchi T; Kitamura H; Kadomura M; Nishimura M; Yokoo T; Imasawa T
    Clin Exp Nephrol; 2019 Apr; 23(4):521-529. PubMed ID: 30467801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the red cell distribution width and diabetic nephropathy in patients with type-2 diabetes mellitus.
    Zhang J; Zhang R; Wang Y; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
    Ren Fail; 2018 Nov; 40(1):590-596. PubMed ID: 30371119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression.
    Zhang J; Xiao X; Wu Y; Yang J; Zou Y; Zhao Y; Yang Q; Liu F
    Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serum alkaline phosphatase and renal outcome in patients with type 2 diabetes mellitus.
    Zhao L; Li L; Ren H; Zou Y; Zhang R; Wang S; Xu H; Zhang J; Liu F
    Ren Fail; 2020 Nov; 42(1):818-828. PubMed ID: 32781868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
    Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
    PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Pathological Characteristics of Patients With Nonproteinuric Diabetic Nephropathy.
    Chang DY; Li MR; Yu XJ; Wang SX; Chen M; Zhao MH
    Front Endocrinol (Lausanne); 2021; 12():761386. PubMed ID: 34764941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.